|
参考文献
1. Chen CC, To WW: Antepartum hemorrhage of unknown origin--what is its clinical significance? Acta Obstet Gynecol Scand, Mar, 1999;78:3, 186-90. (Level II-2)
2. Bricker L, Neilson JP. Routine ultrasound in late pregnancy (after 24 weeks gestation)(Cochrance Review). In: The Cochrance Library, Issue 2 2000. Oxford: Update Software. (Level I)
3. Zaki ZM, Behar AM, Ali ME, Albar HA, Gerais MA: Risk factors and morbidity in patients with placenta previa compared to placenta previa non-accreta. Acta Obstet Gynecol Scand, Apr, 1998;77:4,391-4.(Level III)
4. Miller DA, Chollet JA, Goodwin TM: Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol, Jul. 1997;177:1,210-4. (Level III)
5. Gotoh H, et al Predicting incomplete uterine rupture with vaginal sonography during the late second trimester in women with prior cesarean. 0bstet Gynecol. Apr, 2000;95(4):596-600. (Level 11-2)
6. Crane JM, van den Hof MC, Oodds L, Armsem BA, Ustnn R: Neonatal outcomes with placenta previa, Obstet Gynacol, Apr, 1999;93:4,541-4. (Level III)
7. Neilson JP. Interventions for suspected placenta preavia (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software. (Level I)
8. Towers CV, Pircon RA, Heppard M: Is tocolysis safe in the management of third-trimester bleeding? Am J Obstat Gynecol, Jun, 1999;189:9Pt1,1572-8. (Level 11-2)
9. Frederickson MC, Glassenberg R, Stika CS: Placenta previa: a 22-year analysis. Am J 0bstet Gynecel, Jun, 1999;180:6 Pt1,1432-7. (Level III)
10. Ananth CV, Smulien JC, Vintzileos AM. Incidence of placental abruption in relation to cigarette smoking and hypertensive disorders during pregnancy; a meta-analysis of observational studies. Obstet Gynecol Apr, 1999;93:4,622-9. (Level 11-2)
11. Hulse GK, Milne E, English DR, Holman CD: Assessing the relationship between maternal cocaine use and abruptio placentae. Addiction Nov, 1997;92(11):1547-51. (Level II-2)
12. Rasmussen S, Irgens LM, Dalaker K: The effect on the likelihood of further pregnancy of placental abruption and the rate of its recurrence. Br J Obstet Gynecol Nov, 1997;104(11):1292-5. (Level III)
13. van Rijn M, van der Schouw YT, Hagenaars AM, Viseer GH, Chrisfiansens GC: Adverse obstetric outcome in low- and high-risk pregnancies: predictive value of maternal serum screening. Obstet Gynecol Dec, 1999;94(6):929-34. (Level 11-2)
14. Reis PM, Sander CM, Pearlman MD, Abruptio placentae after auto accidents. A case-control study. Reprod Med. Jan, 2000;45(1):6-10. (Level 11-2)
15. Rogers FB, Rozycki GS, 0slat TM, et el: a multi-institutional study of factors associated with fetal death in injured pregnant patients. Arch Surg Nov, 1999;134(11):1272-7. (Level III)
16. Ananth CV, Berkowitz GS, Savitz DA, Lapinski RH: Placental abruption and adverse perinatal outcomes. JAMA Nov. 1999;3;282(17):I 646-51. (Level 11-2)
17. Hubbard JL, Hosmer SB: Couvelaire uterus. J Am Osteopath Assoc, Sep, 1997;97:9,536-7. (Level III)
18. Neiger R, Krohn H J, Trofatter MO: Plasma fibrin D-dimer in pregnancies complicated by partial placental abruption. Tenn Med, Oct, 1997;900:10,403-5. (Level III)
19. Magriples U, Chan DW, Buzek D, Copel JA, Hsu CD: Thrombomodulin: a new marker for placental abruption. Thromb Haemost, Jan, 1999;81:1,32-4. (Level 11-2)
20. Sher G, Statland BE: Abruptio placentae with coagulopathy; a rational basis for management. Clin 0bstet Gynecol Mar, 1985;28(1):15-23. (Level III)
21. Emery CI, Morway LF, Chung-Park M, Wyatt-Ashmead J, Sawady J, Beddow TD: The Kleihauer-Batke test. Clinical utility, indication, and correlation in patients with placental abruption and cocaine use. Arch Pathol Lab Med Nov, 1995;119(11):1032-7. (Level III)
22. Phelan JP, Korst LM, Settles BK. Uterine activity patterns in uterine rupture: A case control study. Obstet Gynecol 1998;92:394-7. (Level 11-2)
23. Rosen MC, Dickinson JO, Westhoff CL. Vaginal birth after cesarean: A meta-analysis of morbidity and mortality. Obstet Gynecol 1991;77;465-470. (Level 11-2)
24. Leung AS, Laung EK, Paul RH. Uterine rupture after previous cesarean delivery: Maternal and fetal consequences. Am J Obstet Gynecol 1993;169:945-50. (Level III)
25. ACOG Update. VBAC vs. C Section. Vol. 25. No. 12. June 2000 American College of Obstetricians and Gynecologists. Washington, D. C. (Level III)
26. Kirkendall C, Ahn MO, Phelan J. Uterine rupture: a placentally mediated event? Obstet Gynecol. Apr, 2000;1;95(4 Suppl 1):S75. (Level III)
27. Resnick R. Diagnosis and management of placenta accreta. ACOG Clin Rev 1999;4(2):8-9. (Level III)
28. Lee W, et al Vasa previa: prenatal diagnosis, natural evolution, and clinical outcome. 0bstet Gynecol. Apr, 2000;95(4):572-6. (Level III)
29. Harding JA, et. al. Color flow Doppler- a useful instrument in the diagnosis of vasa previa. Am J Obstet Gynecol. Nov, 1990;163(5 Pt. 1):1566-8. (Level III)
上一页 [1] [2] [3] [4] [5] [6] [7]
|